# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-043931
Filing Date
2024-11-07
Accepted
2024-11-07 09:00:46
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1319500
2 |  | ex10-5.htm | EX-10.5 | 10223
3 |  | ex31-1.htm | EX-31.1 | 19410
4 |  | ex31-2.htm | EX-31.2 | 19422
5 |  | ex32-1.htm | EX-32.1 | 8286
6 |  | ex10-5_001.jpg | GRAPHIC | 518107
7 |  | ex10-5_002.jpg | GRAPHIC | 512603
8 |  | ex10-5_003.jpg | GRAPHIC | 452639
9 |  | ex10-5_004.jpg | GRAPHIC | 486148
10 |  | ex10-5_005.jpg | GRAPHIC | 596206
11 |  | ex10-5_006.jpg | GRAPHIC | 497755
12 |  | ex10-5_007.jpg | GRAPHIC | 504962
13 |  | ex10-5_008.jpg | GRAPHIC | 510976
14 |  | ex10-5_009.jpg | GRAPHIC | 390061
15 |  | ex10-5_010.jpg | GRAPHIC | 121084
| Complete submission text file | 0001493152-24-043931.txt |  | 11808957

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
16 | XBRL SCHEMA FILE | imnn-20240930.xsd | EX-101.SCH | 34228
17 | XBRL CALCULATION FILE | imnn-20240930_cal.xml | EX-101.CAL | 48427
18 | XBRL DEFINITION FILE | imnn-20240930_def.xml | EX-101.DEF | 132138
19 | XBRL LABEL FILE | imnn-20240930_lab.xml | EX-101.LAB | 347708
20 | XBRL PRESENTATION FILE | imnn-20240930_pre.xml | EX-101.PRE | 264274
78 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 806810

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 241433432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)